About Jack
When little Jack was diagnosed with DIPG, we asked doctors, a spokesman for a major pharmaceutical company, clinicians--why no effective therapies had been developed for DIPG in so much time. The answer was, "not enough numbers for investors." The anger this statement evoked changed me forever. I was basically being told that my son's life didn't matter to the medical research system. Now it's my life's purpose to see the day when no parent hears this kind of excuse. I love the concept of a non-profit biotech company devoted to finding solutions for childhood cancer. I truly hope it inspires more of the same around the country. You can give here and know exactly what your money is helping. Please give generously.
